跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAR T-cell therapy (lung tumor)
首页
药物
CAR T-cell therapy (lung tumor)
CAR T-cell therapy (lung tumor)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Mutant p53-R175H-based mRNA vaccine and application thereof
CN 118542935 A
申请人: SUZHOU HUAYUAN CELL BIOTECHNOLOGY CO LTD
优先权: 2024
CN
Nanometer antibody targeting CD276 and application thereof
CN 121800921 A
申请人: CYTOTECH BIOPHARMA INC
优先权: 2024
CN
Nanometer antibody specifically combined with CD276 and application thereof
CN 121779559 A
申请人: CYTOTECH BIOPHARMA INC
优先权: 2024
CN
Nanometer antibody and application thereof
CN 121779560 A
申请人: CYTOTECH BIOPHARMA INC
优先权: 2024
CN
RECOMBINANT VECTORS, LENTIVIRUSES, LUNG-EXEMPT MSLN CAR-T CELLS, AND ANTI-TUMOR AGENTS
US 20260183338 A1
申请人: TONGJI HOSPITAL TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV OF SCIENCE AND TECHNOLOGY
优先权: 2024
US
Chimeric antigen receptor fusion protein targeting SIRP gamma, CAR-T cell and application of chimeric antigen receptor fusion protein and CAR-T cell in lung cancer treatment
CN 120118200 A
申请人: SICHUAN PROVINCIAL PEOPLES HOSPITAL SICHUAN ACAD OF MEDICAL SCIENCES
优先权: 2025
CN
Low-expression TSC22D3 enhanced CAR T cell and application thereof
CN 120310742 A
申请人: THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV GUANGZHOU RESPIRATORY CENTER
优先权: 2025
CN
Construction method of animal model for synergistically treating small cell lung cancer by mutant cells and Venotog
CN 120478621 A
申请人: SHANGHAI CHEST HOSPITAL
优先权: 2025
CN
Induced pluripotent stem cell-derived exosome with antitumor activity and application thereof in enhancing CAR-T cell therapy
CN 122124105 A
申请人: THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
优先权: 2026
CN
药物
反馈